For: | Barrows SM, Cai B, Copley-Merriman C, Wright KR, Castro CV, Soufi-Mahjoubi R. Systematic literature review of the antitumor effect of octreotide in neuroendocrine tumors. World J Meta-Anal 2018; 6(2): 9-20 [DOI: 10.13105/wjma.v6.i2.9] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v6/i2/9.htm |
Number | Citing Articles |
1 |
Daneng Li, Christina Darden, Noran Osman, Salma Sayeed, Laurin Jackson, Diana Garbinsky, Aman Chauhan. Real-World Clinical and Patient-Reported Outcomes from the Longitudinal Telotristat Ethyl Treatment Registry of Patients with Neuroendocrine Tumors. Cancer Management and Research 2022; : 3009 doi: 10.2147/CMAR.S386419
|
2 |
Michael A Morse, Eric Liu, Vijay N Joish, Lynn Huynh, Mu Cheng, Mei Sheng Duh, Kiernan Seth, Pablo Lapuerta, David C Metz. <p>Antiproliferative Effects of Telotristat Ethyl in Patients with Neuroendocrine Tumors: The TELEACE Real-World Chart Review Study</p>. Cancer Management and Research 2020; : 6607 doi: 10.2147/CMAR.S261257
|